Elekta
74,92 SEK +1,85 %1 investor følger denne virksomhed
Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.
Omsætning
16,87 mia.
EBIT %
8,48 %
P/E
30,33
Udbytteafkast, %
3,2 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EKTA B
Daglig lav / høj pris
73,94 / 75,8
SEK
Markedsværdi
27,61 mia. SEK
Aktieomsætning
29,8 mio. SEK
Volumen
397 t
Finanskalender
Delårsrapport
30.11.2023
Delårsrapport
29.02.2024
Årsrapport
05.06.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Fjärde AP-fonden | 9,2 % | 6,8 % |
| Laurent Leksell fam och bolag | 5,9 % | 30,4 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper